Modeling Stress-precipitated Smoking Behavior for Medication Development

Conditions

Smoking

What is the purpose of this trial?

The purpose of this study is to examine whether guanfacine or carvedilol will attenuate the ability of stress to precipitate smoking lapse behavior in treatment seeking and non-treatment seeking daily smokers. Participants seeking treatment for smoking will participate in a smoking cessation attempt after the laboratory sessions. Also looking at gender differences.



Participation Guidelines

Age:
18 Years - 60 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute on Drug Abuse (NIDA)
Office of Research on Women's Health (ORWH)
Yale University
Dates:
October 2008
Last Updated:
August 15, 2013
Study HIC#:

Clinicaltrials.gov ID: NCT00773357